STOCK TITAN

Millennium group (SUPN) reports Supernus stake falls below 5% ownership

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Supernus Pharmaceuticals, Inc. is the issuer of common stock reported in this Schedule 13G/A Amendment No. 2. A group including Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander reported historical beneficial ownership positions as of the close of business on June 30, 2026. Integrated Core Strategies (US) LLC reported 3,605,227 shares, representing 6.2% of the common stock, with shared voting and dispositive power over all such shares. Millennium Management LLC, Millennium Group Management LLC and Mr. Englander each reported 3,853,212 shares, representing 6.6% of the class, all with shared voting and dispositive power. The filing states that, as of the date of the amendment, the reporting persons have ceased to beneficially own more than 5% of this class of securities.

Positive

  • None.

Negative

  • None.
Integrated Core Strategies shares 3,605,227 shares Beneficially owned Supernus common stock as of June 30, 2026
Integrated Core Strategies ownership 6.2% Percent of Supernus common stock class as of June 30, 2026
Millennium entities and Englander shares 3,853,212 shares Beneficially owned Supernus common stock as of June 30, 2026
Millennium entities and Englander ownership 6.6% Percent of Supernus common stock class as of June 30, 2026
Ownership status at amendment date Less than 5% Reporting persons ceased to beneficially own more than 5% of the class
beneficially owned financial
"Amount beneficially owned: See response to Item 9 on each cover page."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"Shared Voting Power 3,853,212.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 3,853,212.00"
Schedule 13G regulatory
"Ownership of 5 percent or less of a class "
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
joint filing agreement regulatory
"Exhibit I: Joint Filing Agreement, dated as of August 5, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does this Schedule 13G/A filing mean for Supernus Pharmaceuticals (SUPN)?

The filing shows a group led by Millennium entities and Israel A. Englander reported prior beneficial ownership above 5% of Supernus common stock but has since fallen below the 5% threshold, triggering this amendment.

How many Supernus (SUPN) shares did Millennium entities report owning as of June 30, 2026?

Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each reported 3,853,212 shares of Supernus common stock as of June 30, 2026, representing 6.6% of the outstanding class with shared voting and dispositive power.

What stake did Integrated Core Strategies (US) LLC report in Supernus (SUPN)?

Integrated Core Strategies (US) LLC reported beneficial ownership of 3,605,227 shares of Supernus common stock, equal to 6.2% of the class as of June 30, 2026, with shared voting and dispositive power over those shares.

Are the Millennium reporting persons still more than 5% shareholders of Supernus (SUPN)?

No. The amendment states that, as of its date, the reporting persons have ceased to beneficially own more than 5% of Supernus’s common stock, indicating their ownership has dropped below the key reporting threshold.

Who are the reporting persons in this Supernus (SUPN) Schedule 13G/A amendment?

The reporting persons are Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, acting under a joint filing agreement dated August 5, 2026.

What voting and dispositive powers were reported over Supernus (SUPN) shares?

All reporting persons disclosed 0 shares with sole voting or dispositive power and full positions held with shared voting and shared dispositive power, reflecting coordinated control over the reported Supernus shares.





868459108

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Integrated Core Strategies (US) LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:08/05/2026
Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:08/05/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:08/05/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:08/05/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of August 5, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.